Tuesday, February 25, 2020

Aurobindo Pharma gets EIR with VAI status from USFDA for Hyderabad facility

Aurobindo Pharma gets EIR with VAI status from USFDA for Hyderabad facility According to the US health regulator, a VAI classification "means objectionable conditions or practices were found but the agency is not prepared to take or recommend any administrative or regulatory action".

from Moneycontrol Business News https://ift.tt/32sdjPt
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Small and midcap stocks may face volatility, but long-term returns still strong: Vikas Khemani

​Every day there was some negative news flow, global concern, geopolitical concern, inflation concern, oil prices, commodity, everything was...